USPTO serial 79405474
HCLPEARL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- KHAN, AHSEN M
- Law office
- TMO LAW OFFICE 113
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with HCLPEARL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products for use in industry, science and for research; bacterial, bacteriological, biological, chemical or biochemical preparations for use in industry, science and for research; preparations of micro-organisms, cells, stem cells and bacteria for use in industry, science and for research; chemical products for analyses in laboratories; diagnostic preparations for use in industry, science and for research; chemical, biochemical or biological reagents for use in industry, science and for research; in vitro diagnostic reagents and agents for use in industry, science and for research; cultures of biological tissues and micro-organisms for use in industry, science and for research; micro-biological culture media for use in industry, science and for research; stem cells for use in industry, science and for research; cell culture media for use in industry, science and for research; biological preparations for cell cultures for use in industry, science and for research; tissues and matrices of tissues and organs for scientific, medical and pharmaceutical research; chemical products for the development of biotechnological products for use in industry, science and for research; testing, sampling and diagnostic kits for use in industry, science and for research; chemical test kits comprising reagents, chemical, biochemical or biological agents and products for testing for use in industry, science and for research; chemical, biochemical or biological preparations, and chemical reagents and test kits therefor for research and development relating to pharmaceutical products and medicines, biological tissue repair, replacement of organs or development of artificial organs; test kits for measuring gene expression, secretion and protein activity for use in industry, science and for research; chemical products for encapsulation or coating of active chemical ingredients for use in industry, science and for research; chemical products for cell encapsulation for use in industry, science and for research; chemical products for three-dimensional cell culture for use in industry, science and for research; encapsulated biological products with cell culture for medical, pharmaceutical, scientific use, for diagnosis and for research; cells, stem cells and encapsulated or co-encapsulated microorganisms secreting biological products for medical, pharmaceutical, scientific use, for diagnosis and for research; encapsulated biological products with liver cells for medical, pharmaceutical, scientific, diagnostic and research use; encapsulated liver cells secreting biological products for medical, pharmaceutical, scientific, diagnostic and research use. | ACTIVE | — |
| 005 | Pharmaceutical products, medical and veterinary preparations; sanitary products for medicine; dietetic substances and foodstuffs for medical or veterinary use, food for babies; dietary supplements for humans and animals; plasters, material for dressings; materials for dental fillings and dental impressions; disinfectants; products for destroying vermin; fungicides, herbicides; bacterial, bacteriological, biological or chemical preparations for medical or veterinary use; preparations of micro-organisms, cells, stem cells and bacteria for medical or veterinary use; diagnostic preparations for medical or veterinary use; chemical, biochemical or biological reagents for medical or veterinary use; diagnostic biomarking reagents for medical use; in vitro diagnostic reagents and agents for medical or veterinary use; cultures of biological tissues and microorganisms for medical or veterinary use; micro-biological culture media for medical or veterinary use; cells and stem cells for medical or veterinary use; cell culture media for medical or veterinary use; biological preparations for cell culture for medical or veterinary use; tissues and matrices of tissues and organs for medical or veterinary use; chemical products for the development of pharmaceutical and biotechnological products for medical or veterinary use; surgical implants made of living tissue; grafts [living tissues]; living tissues, micro-tissues and organs for medical or veterinary use; preparations for 3D bio-printing of living tissues, micro-tissues and organs for medical or veterinary use; pharmaceutical products for tissue regeneration, tissue repair or tissue processing for medical or veterinary use; testing, sampling and diagnostic kits for medical or veterinary use; testing kits comprising reagents, chemical, biochemical, biological or pharmaceutical agents and products for testing for medical and veterinary use; chemical, biochemical or biological preparations, and chemical reagents and test kits therefor for medical or veterinary use for the development of pharmaceutical products and medicines, for biological tissue repair, replacement of organs or development of artificial organs; test kits for measuring gene expression, secretion and protein activity for medical or veterinary use; chemical products for use in encapsulation and coating of active ingredients and pharmaceutical substances for medical or veterinary use; chemical products for cell encapsulation for medical or veterinary use; chemical products for three dimensional cell culture for medical or veterinary use; cartridges containing tissues, micro-tissues or organs for transplantation for medical or veterinary use; cartridges containing tissues, micro-tissues or organs for integration for integration into bio-artificial extra-corporal organ machines and apparatus for medical or veterinary use; biological products encapsulated with cell cultures for medical, veterinary or pharmaceutical or veterinary use; cells, stem cells and encapsulated or co-encapsulated microorganisms secreting biological products for medical, pharmaceutical or veterinary use; encapsulated biological products with liver cells for medical, pharmaceutical or veterinary use; encapsulated liver cells secreting biological products for medical, pharmaceutical or veterinary use. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 20, 2026 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 5, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 5, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 19, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 2, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 2, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 5, 2025 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 5, 2025 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 26, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 9, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 18, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 18, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 21, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 20, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 15, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 15, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 3, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |